Clinical Trial Update: RADAR Trial - Randomised Androgen Deprivation and Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 RADAR trial evaluating androgen deprivation with radiotherapy for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED